We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STEX
10301
Streamex Corp
STEX
$81.2M
$68K ﹤0.01%
+1,744
New +$76.7K
CPRX
10302
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$68K ﹤0.01%
20,400
-2,000
-9% -$6.72K
LTBR icon
10303
Lightbridge
LTBR
$294M
$68K ﹤0.01%
+15,961
New +$51.4K
LITS
10304
CALL
Lite Strategy Inc
LITS
$32.4M
$68K ﹤0.01%
1,285
-2,010
-61% -$116K
PRQR icon
10305
PUT
ProQR Therapeutics
PRQR
$253M
$68K ﹤0.01%
+16,200
New +$68.3K
FNHC
10306
DELISTED
FedNat Holding Company Common Stock
FNHC
$68K ﹤0.01%
+11,490
New +$65.6K
STON
10307
CALL
DELISTED
StoneMor Inc.
STON
$68K ﹤0.01%
25,700
-3,700
-13% -$4.88K
BDSI
10308
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$68K ﹤0.01%
16,100
-39,900
-71% -$154K
KOPN icon
10309
PUT
Kopin
KOPN
$784M
$67K ﹤0.01%
+27,600
New +$45K
LTRX icon
10310
Lantronix
LTRX
$273M
$67K ﹤0.01%
+15,204
New +$71.1K
MRKR icon
10311
Marker Therapeutics
MRKR
$21.2M
$67K ﹤0.01%
4,654
-220
-5% -$3.42K
SMHI icon
10312
SEACOR Marine Holdings
SMHI
$259M
$67K ﹤0.01%
+24,905
New +$52.7K
TRX icon
10313
TRX Gold Corp
TRX
$265M
$67K ﹤0.01%
101,282
+24,485
+32% +$16K
TWM icon
10314
ProShares UltraShort Russell2000
TWM
$41.3M
$67K ﹤0.01%
+671
New +$88.7K
VATE icon
10315
CALL
INNOVATE Corp
VATE
$108M
$67K ﹤0.01%
2,040
-960
-32% -$26.7K
SCNX
10316
Scienture Holdings
SCNX
$15.6M
$67K ﹤0.01%
+847
New +$68.3K
ADMS
10317
PUT
DELISTED
Adamas Pharmaceuticals
ADMS
$67K ﹤0.01%
+15,400
New +$65.9K
BNKK
10318
Bonk Inc
BNKK
$8.48M
$66K ﹤0.01%
+370
New +$61.5K
VCNX
10319
CALL
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$66K ﹤0.01%
+152
New +$63.6K
ASLN
10320
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$66K ﹤0.01%
+899
New +$66K
OBSV
10321
CALL
DELISTED
ObsEva SA Ordinary Shares
OBSV
$66K ﹤0.01%
31,700
+19,100
+152% +$41.4K
RJA
10322
PUT
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
$66K ﹤0.01%
+10,000
New +$59.4K
NFH.WS
10323
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$66K ﹤0.01%
30,445
+115
+0.4% +$228
ADAP
10324
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
$65K ﹤0.01%
12,000
-5,300
-31% -$28.8K
EGY icon
10325
Vaalco Energy
EGY
$552M
$65K ﹤0.01%
+36,468
New +$46.8K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.